NCT00147914View on ClinicalTrials.gov

Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 18, 2017

Conditions
Acute Bacterial Sinusitis
Interventions
DRUG

Cefdinir (drug)

cefdinir 300mg per orally twice daily for 10 days

DRUG

amoxicillin/clavulanate

1000mg /62.5mg extended release per orally twice daily for 10 days

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT00147914 - Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life | Biotech Hunter | Biotech Hunter